The FDA has granted Compass Pathways with a rolling review for a New Drug Application (NDA) for its investigational ...
In today’s Pharmaceutical Executive Daily, the FDA issues a complete response letter to AbbVie for a biologics license ...
Regeneron reached an agreement with the U.S. government to link current and future drug prices to those in other developed ...
AbbVie received a Complete Response Letter (CRL) from the FDA for its Biologics License Application (BLA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results